B
Ecosystem Profile
Biossil
Biotech startup that uses an AI platform to identify and develop discarded drug molecules for new therapies.
1
Dispatches
Apr 25, 2026
Last Signal
Full Coverage Archive
Biossil Repurposes Failed Drug Candidates Using Advanced AI Platform
AI platform for molecular identification and drug development.Apr 25, 20262 min
Biossil Repurposes Failed Drug Candidates Using Advanced AI Platform
The challenge of drug discovery has historically been defined by attrition. A molecule can show immense promise, only to fall through the rigorous gauntlet of preclinical and early clinical testing for reasons...
↗ Biossil leverages AI to solve the 'drug attrition' problem by repositioning discarded molecular candidates, drastically reducing the time and cost associated with early-stage drug development and offering a novel revenue stream from 'failed' scientific data.